Menu Menu

AGIO    Agios Pharmaceuticals Inc    1439222    
Income Statement
Revenue 36,498,000
Net Income 673,725,000
Profit Margin 1845.92%

Balance Sheet
Current Assets 965,600,000
Assets 1,663,199,000
Current Liabilities 81,156,000
Liabilities 122,243,000
Equity 1,540,956,000
Shares Out 56,893,000

Cash Flow Statement
Operating Cash Flow -389,841,000
Investing Cash Flow 363,441,000

Market Analysis
Market Cap 2,643,254,303
Price 32.12
BVPS 27.09
PB 1.16
EPS -6.49
PS 18.11
FCF -26,400,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/13 11.86
Apr May Jun
5/02 -1.45
Jul Aug Sep
8/01 -1.69
Oct Nov Dec
10/31

Find a discrepancy? The most accurate way to find company fundamental data is to view AGIO documents filed with the SEC.


AGIO Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: